1Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association[J]. Circulation, 2014, 129(3): e28-292.
2Meschia JF, Bushnell C, Boden AB, et al. Guidelines for the primary prevention of stroke : a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(12): 3754-3832.
3Bushnell C, MeCuUangh LD, Awad IA, et al. Guidelines for the prevention of stroke in women: a statement for healtheare professionals from the American Heart Association/American Stroke Association[ J]. Stroke, 2014-, 45 (5) : 1545-1588.
4ACCORD Study Group, Cushman WC, Evans GW, et al. Effectsof intensive blood-pressure control in type 2 diabetes mellitus[ J]. N Engl J Med, 2010, 362(17) : 1575-1585.
5Wald DS, Wald NJ. Implementation of a simple age-based strategy in the prevention of cardiovascular disease: the Polypill approach[J]. J Eval Clin Pract, 2012, 18(3) : 612-615.
6Olesen JB, Torp PC, Hansen ML, et al. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study [J]. Thromb Haemost, 2012, 107 (6) : 1172-1179.
7Hohnloser SH, Oldgren J, Yang S, et al. Myocardial isehemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial[ J]. Circulation, 2012, 125 ( 5 ) : 669-676.
8Patel MR, Mahaffey KW, Garg J, et al. ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation [ J ]. N Engl J Med, 2011, 365 ( 10 ) : 883-891.
9Granger CB, Alexander JH, McMurray JJ, et al. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation [ J]. N Engl J Med, 2011,365 ( 11 ) : 981 - 992.
10O' Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction : executive summary : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [ J ]. J Am Call Cardiol, 2013, 61 (4) : 485- 510.
